Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome

Fig. 4

Pathway analysis of the differential metabolites between PCOS versus CON group. a Pathway analysis result of differential metabolites between PCOS versus control group using over-representation method in MetaboAnalyst website (p value < 0.05 of t-test after FDR adjusting). Hypergeometric test and relative betweeness centrality algorithm were used for pathway topology analysis, human KEGG pathway library was used. b Metabolites set enrichment analysis of all metabolites with HMBD identifier using quantitative enrichment analysis method. Pathway-associated metabolite sets (KEGG) containing 84 metabolite sets based on normal human metabolic pathways were used for this MSEA

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us